Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial.
about
Genome-wide association with bone mass and geometry in the Framingham Heart StudyRefined QTLs of osteoporosis-related traits by linkage analysis with genome-wide SNPs: Framingham SHAReWomen with hip fracture experience greater loss of geometric strength in the contralateral hip during the year following fracture than age-matched controls.The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial.Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update.Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).Rheumatoid arthritis is associated with less optimal hip structural geometryAn in vivo comparison of hip structure analysis (HSA) with measurements obtained by QCT.Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis StudyBone geometry profiles in women with and without SLE.Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women.Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials.Effect of monthly ibandronate on hip structural geometry in men with low bone density.Inter-sex differences in structural properties of aging femora: implications on differential bone fragility: a cadaver study.Combined use of ibandronate and eldecalcitol in postmenopausal Japanese women with osteoporosis.
P2860
Q21093326-78484CED-4A3B-4497-822D-7D3530717CF9Q33742242-F8402D7C-01A4-41F6-A7AF-E29ADFF05F35Q33759441-6F7A4CEA-3330-4A5F-97C7-22377A8F9183Q33802932-A81B12A0-BAC0-41EC-97F9-424E2D0C5278Q34272056-EDA35CC8-7873-4D2E-8163-195BC4F6E4A3Q34482507-57F2E7EE-6EE4-4D28-A149-1AA1E0562C25Q35566318-23ABAB24-49CF-4A78-873B-B202F853ACD1Q35681168-0DBE7E35-DC49-4DCF-B70D-D9B70AE6646BQ35950352-63397A30-B2FC-4E24-B00A-FB8DC82E6BE3Q36844182-0A49CC6E-AD39-4CC1-8906-C5B87F9F43A2Q36976210-86D51996-CFD7-4424-940E-1C9E558D2B9DQ37053045-EC1B126B-2023-4904-A200-B4918CF9D3FAQ37203453-A45CAC84-E825-490C-9EE0-7B4E9AB6AF35Q46047966-060CC6D9-1F91-444C-8574-06EFEDA1C7A9Q47338818-AD9C44AD-89D1-4768-A434-87EA14B34820Q54205972-EF5724CF-C8E7-4655-BE35-62ECC94DC07C
P2860
Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Structural effects of raloxife ...... f raloxifene evaluation trial.
@en
Structural effects of raloxife ...... f raloxifene evaluation trial.
@nl
type
label
Structural effects of raloxife ...... f raloxifene evaluation trial.
@en
Structural effects of raloxife ...... f raloxifene evaluation trial.
@nl
prefLabel
Structural effects of raloxife ...... f raloxifene evaluation trial.
@en
Structural effects of raloxife ...... f raloxifene evaluation trial.
@nl
P2093
P1476
Structural effects of raloxife ...... f raloxifene evaluation trial.
@en
P2093
K D Harper
K Uusi-Rasi
L M Semanick
M M Daphtary
P2888
P304
P356
10.1007/S00198-005-0028-3
P407
P577
2006-01-04T00:00:00Z